Genetic testing for neuromuscular disorders - new pathology MBS items 73422 to 73428

From 1 November 2022, seven new items (73422, 73423, 73424, 73425, 73426, 73427 and 73428) for genetic testing for the diagnosis of NMDs will be listed on the MBS. The new MBS items will be available for patients who are suspected of having NMDs, biological relatives of affected individuals for the purpose of identifying the causative variant(s), reproductive partners of patients who have been diagnosed with an inherited genetic variant linked to a NMD, and data re-analysis to support re-testing where new genetic variants of significance are identified.

The Medical Services Advisory Committee (MSAC) supported the creation of new MBS items for the genetic testing of eligible patients for the purposes of diagnosis, providing prognostic information, enabling cascade testing of at-risk family members and enabling informed reproductive decision-making.

Further information is available in the following factsheets:

PDF Version New pathology MBS items for genetic testing for neuromuscular disorders (PDF 229 KB)
Word Version New pathology MBS items for genetic testing for neuromuscular disorders (Word 124 KB)